Pharmalot

By  Ed Silverman

Taking stock of the drug industry, from the lab to the medicine chest. Sign up for the newsletter here.

drug compound
Pharmalot

Pharmacy groups seek to break an impasse over FDA framework for monitoring compounders

By Ed Silverman

Pharmalot

Pharmalittle: Female CEOs in biotech are still rare; Arizona sues Sacklers in Supreme Court

By Ed Silverman

Pharmalot

Pharmalittle: Trump unveils plan to allow drug imports from Canada; fed probe into generic price fixing hits roadblocks

By Ed Silverman

Colorful selection of pills
Pharmalot

A pharma effort to combat noncommunicable diseases in developing countries gets mixed reviews

By Ed Silverman

Pharmalot

Pharmalittle: Amazon’s PillPack rival seeks help from FBI; a big payday for Mylan’s CEO

By Ed Silverman

Insulin factory - Novo
Pharmalot

New York attorney general probes big three insulin makers over their pricing

By Ed Silverman

Pharmalot
Pharmalot

Teva and Endo reach settlements with California over pay-to-delay deals

By Ed Silverman

Mylan
Pharmalot

For Mylan shareholders, the deal with Pfizer will ‘solve nothing’

By Ed Silverman

Jae C. Hong/AP
Pharmalot

As Bernie Sanders neared, Canadian officials were urged not to allow U.S. to import medicines

By Ed Silverman

Pharmalot

Pharmalittle: Pfizer to merge off-patent business with Mylan; conservatives try to sabotage Trump pricing plan

By Ed Silverman

Hires
Pharmalot

Up and down the ladder: The latest comings and goings

By Ed Silverman

Pharmalot

Pharmalittle: Pharma meets with Trump over Senate bill; McKinsey advised J&J on opioid sales

By Ed Silverman

Pharmalot

Few medical journals disclose conflicts held by their own editorial teams

By Ed Silverman

A dosage of Spinraza.
Pharmalot

Consumer groups urge Italian and Belgian authorities to investigate Biogen over Spinraza pricing

By Ed Silverman

Pharmalot

Pharmalittle: Trump eyes executive order for drug pricing; opioid makers ask judge to toss a key lawsuit

By Ed Silverman

Sen. Elizabeth Warren
Pharmalot

Elizabeth Warren presses Pfizer to fork over information on Scott Gottlieb

By Ed Silverman

Pharmalot

Medicare paid for medicines that three other wealthy nations decided had little value

By Ed Silverman

Opioid Lawyers
Pharmalot

Sun Pharma sales rep claims he was fired for complaining about off-label marketing

By Ed Silverman

Pharmalot

Pharmalittle: New records show drug makers’ opioid push; Senate bill would cap Medicare drug price hikes

By Ed Silverman

Elephant
Pharmalot

Pharma contributions to politicians who support restricting abortions could reverberate

By Ed Silverman

AmerisourceBergen
Pharmalot

California cites AmerisourceBergen for failing to flag huge sales of opioids to pharmacies

By Ed Silverman

Charlie Baker
Pharmalot

Massachusetts lawmakers approve compromise bill to lower Medicaid drug spending

By Ed Silverman

Pharmalot

Pharmalittle: 23andMe’s Glaxo deal raises ethical questions; Dems to unveil drug pricing bill in September

By Ed Silverman

Pharmalot

European Medicines Agency is advised to take steps to avoid bias concerns over approvals

By Ed Silverman

Pharmalot

Pharmalittle: Opioid companies failed to halt suspicious orders; U.K. diabetics are rationing insulin

By Ed Silverman

Hires
Pharmalot

Up and down the ladder: The latest comings and goings

By Ed Silverman

Pharmalot

Pharmalittle: Canada throws cold water on U.S. drug importation; was FDA’s ‘smart pill’ approval smart?

By Elizabeth Cooney

FDA Campus
Pharmalot

Was it really a smart move for the FDA to approve a ‘smart pill’ for treating schizophrenia?

By Ed Silverman

Pharmalot

Pharmalittle: Women make ‘little progress’ in key pharma roles; FDA approves a Merck antibiotic

By Ed Silverman

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy